'Up to one in 10 women could benefit from anti-cancer treatments such as tamoxifen even before they show signs of the disease, according to an international panel of experts.
But there are concerns the drug could have side-effects, such as blood clots and, in some cases, womb cancer.
In a paper published today in The Lancet Oncology, the specialists call for a radical new approach to identifying and treating patients who are at risk.'
'This 'International Panel of Experts' is lead by Professor Jack Cusick of the Wolfson Institute, an organisation funded by the Rothschilds, City of London Corporation and a plethora of Big Pharma Companies. No conflict of interest there then!'
Editor's Note: David Icke posted the above satirical comment in italics and linked to the UK mainstream article which wrote the Big Pharma press release.
Read the Telegraph article to which David Icke referred here ...
But here's an interesting excerpt from elsewhere: 'In September 2000, The Lancet reported a study which showed that the drug tamoxifen, often used to treat breast cancer and as a preventive in some high risk women as well, increased the risk of developing endometrial cancer. In addition, this risk increased with time, leading researchers to question the use of the drug in healthy women. It found that women who took tamoxifen for 2 to 5 years had twice the risk of the cancer as women who have not taken it. Women who had taken it for 5 years or more have a seven times higher risk of endometrial cancer. The total increased risk for all women who used tamoxifen at all was 50%. Advanced endometrial cancers were more common in women who had taken tamoxifen long-term than in those who had not. The 3-year survival for endometrial cancer was "significantly worse" for long-term tamoxifen users.' Excerpted from this article here ...
Read the Telegraph article to which David Icke referred here ...
But here's an interesting excerpt from elsewhere: 'In September 2000, The Lancet reported a study which showed that the drug tamoxifen, often used to treat breast cancer and as a preventive in some high risk women as well, increased the risk of developing endometrial cancer. In addition, this risk increased with time, leading researchers to question the use of the drug in healthy women. It found that women who took tamoxifen for 2 to 5 years had twice the risk of the cancer as women who have not taken it. Women who had taken it for 5 years or more have a seven times higher risk of endometrial cancer. The total increased risk for all women who used tamoxifen at all was 50%. Advanced endometrial cancers were more common in women who had taken tamoxifen long-term than in those who had not. The 3-year survival for endometrial cancer was "significantly worse" for long-term tamoxifen users.' Excerpted from this article here ...
Related Post:
Widget by [ Iptek-4u ]
